EVALUATION OF SERUM LEVEL OF ANTI-MÜLLERIAN HORMONE  IN PRE-ECLAMPSIA

Wasan Wajdi; Ishraq Mohammed Kadhim; Raghad Nabeel Al-Khayyat

doi:10.5937/afmnai42-55303

Research paper

Published: 31.10.2025.

<< Prev | Next >>

PDF

https://doi.org/10.5937/afmnai42-55303

EVALUATION OF SERUM LEVEL OF ANTI-MÜLLERIAN HORMONE IN PRE-ECLAMPSIA

Abstract

Pre-eclampsia is a multiorgan disease process characterized by hypertension and proteinuria after 20 weeks of gestation. The aim of the study was to assess the serum level of anti-Müllerian hormone (AMH) in pregnant women as a predictor for pre-eclampsia. A case control study was carried out in Baghdad Teaching Hospital from 2020 to 2021. A sample of 192 pregnant women in the third trimester participated in the study and were divided into two main groups. The first group enrolled 96 normotensive pregnant women (control group), and the second group included 96 patients with pre-eclampsia (as a case group). The latter group was subdivided into 36 patients with mild to moderate pre-eclampsia, and 60 with severe pre eclampsia. Blood samples were taken from each woman (case and control group) to test the AMH level, liver function tests, renal function tests, serum uric acid, serum lactate dehydrogenase (LDH), and complete blood picture. Urine samples were analyzed for albumin concentration and spot urine was assessed for protein-to-creatinine ratio. Anti-Müllerian hormone levels were significantly lower in the case group than in the control group (p < 0.001). In the control group, the AMH level was 4.92 ± 1.79 ng/ml, while for mild to moderate pre-eclampsia group, it was 1.56 ± 0.21 ng/ml, and 0.42 ± 0.38 ng/ml for severe pre-eclampsia. Systolic and diastolic blood pressure showed significant higher values in the case group (p < 0.001). Gestational age, serum uric acid and serum albumin had moderate correlation with AMH in pre-eclampsia with significant association. The level of AMH was decreased significantly in pregnant women with pre-eclampsia in comparison to healthy
pregnancy.

Keywords:

anti-Mullerian hormone,

pre-eclampsia,

blood pressure

References

Tokmak A, Güney G, Aksoy RT, Guzel AI, Topcu HO, Keçecioğlu TS, et al. May maternal anti-mullerian hormone levels predict adverse maternal and perinatal outcomes in preeclampsia? The Journal of Maternal-Fetal & Neonatal Medicine. 2014;28(12):1451–6.

Shand AW, Whitton K, Pasfield A, Nassar N, McShane M, Han X, et al. Evaluation of anti‐Mullerian hormone in the first trimester as a predictor for hypertensive disorders of pregnancy and other adverse pregnancy outcomes. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2014;54(3):244–9.

Aydoğan Mathyk B, Aslan Çetin B, Gülova S, Yenigül N, Ayhan I, Ender Yumru A. The impact of serum anti-Müllerian hormone levels on preeclampsia prediction: a case control study. Perinatal Journal. 2018;26(2):92–6.

Jamil Z, Shahid S, Baig E, Ahmad R, Subhani F, Fatima SS. Serum anti mullerian hormone and renalase levels in predicting the risk of preeclampsia. Taiwanese Journal of Obstetrics and Gynecology. 2019;58(2):188–91.

Bhide P, Vårtun Å, Aune B, Flo K, Basnet P, Acharya G. Ovarian reserve in women with a previous history of severe pre-eclampsia. Archives of Gynecology and Obstetrics. 2016;295(1):233–8.

Agabain E, Mohamed H, Elsheikh AE, Hamdan HZ, Adam I. Maternal serum anti-Müllerian hormone in Sudanese women with preeclampsia. BMC Research Notes. 2017;10(1).

Gowkielewicz M, Lipka A, Zdanowski W, Waśniewski T, Majewska M, Carlberg C. Anti-Müllerian hormone: biology and role in endocrinology and cancers. Frontiers in Endocrinology. 2024;15.

Belville C, Van Vlijmen H, Ehrenfels C, Pepinsky B, Rezaie AR, Picard JY, et al. Mutations of the Anti-Müllerian Hormone Gene in Patients with Persistent Müllerian Duct Syndrome: Biosynthesis, Secretion, and Processing of the Abnormal Proteins and Analysis Using a Three-Dimensional Model. Molecular Endocrinology. 2004;18(3):708–21.

Köninger A, Kauth A, Schmidt B, Schmidt M, Yerlikaya G, Kasimir-Bauer S, et al. Anti-Mullerian-hormone levels during pregnancy and postpartum. Reproductive Biology and Endocrinology. 2013;11(1):60.

10.

Pergialiotis V, Koutaki D, Christopoulos-Timogiannakis E. Anti-müllerian hormone levels in preeclampsia: a systematic review of the literature. J Fam Reprod Health. 2017;(4):179.

11.

Yarde F, Maas AHEM, Franx A, Eijkemans MJC, Drost JT, van Rijn BB, et al. Serum AMH Levels in Women With a History of Preeclampsia Suggest a Role for Vascular Factors in Ovarian Aging. The Journal of Clinical Endocrinology & Metabolism. 2014;99(2):579–86.

12.

Woldringh GH, Frunt MHA, Kremer JAM, Spaanderman MEA. Decreased ovarian reserve relates to pre-eclampsia in IVF/ICSI pregnancies. Human Reproduction. 2006;21(11):2948–54.